中国科学院机构知识库网格系统: 检索

浏览/检索结果: 共9条，第1-9条

帮助

条数/页：排序方式：
	Targeting HER2 Aberrations in Non-Small Cell Lung Cancer with Osimertinib 期刊论文 OAI收割 CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 11, 页码: 2594-2604 作者: Liu, Shengwu; Hai, Josephine; Wang, Xiaoen; Quinn, Max M.; Gao, Peng \| 收藏 \| 浏览/下载：95/0 \| 提交时间：2019/04/28 Receptor Tyrosine Kinase Phase-ii Trial Bromodomain Inhibition Combination Therapy Acquired-resistance Domain Mutations Bet Bromodomains Breast-cancer Egfr Mutant
	Current Status and Future Prospects of Polymeric Nanocarrier for Tumor Targeting 期刊论文 OAI收割高等学校化学学报 chemical journal of chinese universities-chinese, 2014, 卷号: 35, 期号: 5, 页码: 903-916 Yu Haiyang; Tang Zhaohui; Song Wantong; Deng,Mingxiao; Chen,Xuesi 收藏 \| 浏览/下载：43/0 \| 提交时间：2015/10/22 INTRACELLULAR DRUG-DELIVERY CELL LUNG-CANCER PHASE-II TRIAL MONOCLONAL-ANTIBODY IN-VITRO POLYPEPTIDE NANOGELS TRANSFERRIN-RECEPTOR BLOCK-COPOLYMER CREMOPHOR-FREE GENEXOL-PM
	Preclinical pharmacology and toxicology study of Ad-hTERT-E1a-Apoptin, a novel dual cancer-specific oncolytic adenovirus 期刊论文 OAI收割 toxicology and applied pharmacology, 2014, 卷号: 280, 期号: 2, 页码: 362-369 Qi, Yanxin; Guo, Huanhuan; Hu, Ningning; He,Dongyun; Zhang,Shi; Chu,Yunjie; Huang,Yubin; Li,Xiao; Sun,Lili; Jin,Ningyi 收藏 \| 浏览/下载：35/0 \| 提交时间：2015/10/20 REPLICATION-SELECTIVE ADENOVIRUS PHASE-II TRIAL GENE-THERAPY NECK-CANCER CLINICAL-TRIALS APOPTIN ONYX-015 CARCINOMA ANIMALS SAFETY
	Chemotherapy with or without irinotecan in patients with advanced or recurrent gastric cancer: a meta-analysis of randomized controlled trials 期刊论文 OAI收割 CHINESE MEDICAL JOURNAL, 2014, 卷号: 127 - \| 收藏 \| 浏览/下载：13/0 \| 提交时间：2020/10/26 PHASE-II TRIAL SUPPORTIVE CARE 1ST-LINE TREATMENT PLUS CISPLATIN FOLINIC ACID 5-FLUOROURACIL LEUCOVORIN ADENOCARCINOMA FLUOROURACIL CARCINOMA irinotecan gastric cancer meta-analysis
	THE PROGRESS PROGRESS AND EXPECTATION OF POLYMER PHARMACY 期刊论文 OAI收割 acta polymerica sinica, 2013, 期号: 6, 页码: 733-749 Hu XL; Xie ZG; Huang YB; Jing XB 收藏 \| 浏览/下载：33/0 \| 提交时间：2014/04/20 INCORPORATING MICELLAR NANOPARTICLE DRUG-DELIVERY SYSTEM ENHANCED ANTITUMOR-ACTIVITY ENZYME PRODRUG THERAPY METAL COMPLEX MICELLE ACID) BLOCK-COPOLYMER PHASE-II TRIAL HPMA COPOLYMERS IN-VIVO BIODEGRADABLE POLYMER
	Antitumor activity of folate-targeted, paclitaxel-loaded polymeric micelles on a human esophageal EC9706 cancer cell line 期刊论文 OAI收割 international journal of nanomedicine, 2012, 卷号: 7, 页码: 3487-3502 Wu WB; Zheng YH; Wang R; Huang WL; Liu L; Hu XL; Liu S; Yue J; Tong T; Jing XB 收藏 \| 浏览/下载：25/0 \| 提交时间：2013/06/30 PHASE-II TRIAL IN-VITRO BLOCK-COPOLYMER CASPASE-3 EXPRESSION RADIATION-THERAPY UP-REGULATION CARCINOMA CHEMORADIOTHERAPY APOPTOSIS BAX
	Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study 期刊论文 OAI收割 WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 卷号: 17 - \| 收藏 \| 浏览/下载：27/0 \| 提交时间：2020/10/26 GROWTH-FACTOR-RECEPTOR PHASE-II TRIAL FLUOROURACIL FAILURE 1ST-LINE TREATMENT RANDOMIZED-TRIAL CHEMOTHERAPY OXALIPLATIN EXPRESSION INFUSION SURVIVAL Epidermal growth factor receptor Cetuximab Irinotecan Metastatic colorectal cancer Asia